Literature DB >> 12385404

International application of the incidence rate/window period model.

Simone A Glynn, Steven H Kleinman, David J Wright, Michael P Busch.   

Abstract

Mesh：

Year:  2002        PMID： 12385404     DOI： 10.1046/j.1537-2995.2002.00200.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  19 in total

1.  Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec.

Authors:  Marc Germain; Stéphanie Gélinas; Gilles Delage
Journal:  CMAJ       Date:  2004-03-30       Impact factor: 8.262

2.  Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.

Authors:  John P Pitman; Sridhar V Basavaraju; Ray W Shiraishi; Robert Wilkinson; Bjorn von Finckenstein; David W Lowrance; Anthony A Marfin; Maarten Postma; Mary Mataranyika; Cees Th Smit Sibinga
Journal:  Transfusion       Date:  2015-02-27       Impact factor: 3.157

3.  Safety in transfusion medicine.

Authors:  Giuseppe Aprili
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

4.  HCV RNA Testing of Plasma Samples from Cornea Donors: Suitability of Plasma Samples Stored at 4 °C for up to 8 Days.

Authors:  Annemarie Berger; Sabine Salla; Oliver T Keppler; Holger F Rabenau
Journal:  Transfus Med Hemother       Date:  2016-11-04       Impact factor: 3.747

5.  Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples.

Authors:  Lena Novack; Noya Galai; Arieh Yaari; Mordechai Orgel; Eilat Shinar; Batia Sarov
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.

Authors:  Syria Laperche; Nadine Le Marrec; Annie Girault; Françoise Bouchardeau; Annabelle Servant-Delmas; Michèle Maniez-Montreuil; Pierre Gallian; Thierry Levayer; Pascal Morel; Nicole Simon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018.

Authors:  Claudio Velati; Luisa Romanò; Ilaria Pati; Giuseppe Marano; Vanessa Piccinini; Liviana Catalano; Simonetta Pupella; Stefania Vaglio; Eva Veropalumbo; Francesca Masiello; Giulio Pisani; Giuliano Grazzini; Alessandro Zanetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

8.  Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran.

Authors:  Hamid Reza Saber; Seyed Morteza Tabatabaee; Ali Abasian; Mostafa Jamali; Ebadollah SalekMoghadam; Bashir Hajibeigi; Seyed Moayed Alavian; Seyed Mohammad Mirrezaie
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-01       Impact factor: 0.900

9.  Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey.

Authors:  Claudio Velati; Luisa Romanò; Vanessa Piccinini; Giuseppe Marano; Liviana Catalano; Simonetta Pupella; Giuseppina Facco; Ilaria Pati; Maria Elena Tosti; Stefania Vaglio; Giuliano Grazzini; Alessandro Zanetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-06-26       Impact factor: 3.443

10.  Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Authors:  Jo Anne Chiavetta; Michael Escobar; Alice Newman; Yaohua He; Pete Driezen; Shelley Deeks; Devon E Hone; Sheila F O'Brien; Graham Sher
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.